$オーケストラ バイオーム ホールディングス(OBIO.US)$The FDA Granted An Investigational Device Exemption To Initiate BACKBEAT Study Evaluating Orchestra Biomed's Atrioventricular Interval Modulation Therapy (BACKBEAT CNT) For Hypertensive Patients Who Are Indicated For A Dual-chamber Cardiac Pacemaker
$オーケストラ バイオーム ホールディングス(OBIO.US)$I have been following and profitting on for weeks now. There is an ascending triangle formed and there should be a breakout within the next few days. We shall see.
Rivera : Nicee el move
SoCalCommish760スレ主 Rivera: What you think?
Rivera SoCalCommish760スレ主: Look for 11-15